Loading of a novel angiogenic agent, ginsenoside Rg1 in an acellular biological tissue for tissue regeneration

Tissue Engineering

Volumn 11, Issue 5-6, 2005, Pages 835-846

  Liang, Huang Chien ^a   Chen, Chiung Tong ^b   Chang, Yen ^c   Huang, Ya Chun ^a   Chen, Sung Ching ^a   Sung, Hsing Wen ^a  

^a NATIONAL TSING HUA UNIVERSITY   (Taiwan)

^b NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^c NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGRAPHY; BIOMEDICAL ENGINEERING; CAPILLARY FLOW; CELLS; PROTEINS;

ACELLULAR TISSUES; HUMAN UMBILICAL VEIN ENDOTHELIAL CELL (HUVEC); PANAX GINSENG; TISSUE REGENERATION;

TISSUE;

BASIC FIBROBLAST GROWTH FACTOR; BIOMATERIAL; GENIPIN; GINSENOSIDE RG 1; MATRIGEL; UNCLASSIFIED DRUG;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ASSAY; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; EXTRACELLULAR MATRIX; GINSENG; IN VITRO STUDY; IN VIVO STUDY; MALE; NONHUMAN; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN STABILITY; RAT; TISSUE REGENERATION;

ANGIOGENESIS INDUCING AGENTS; ANIMALS; CALORIMETRY, DIFFERENTIAL SCANNING; CELL MOVEMENT; CELL PROLIFERATION; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; EXTRACELLULAR MATRIX; GINSENOSIDES; HEAT; HUMANS; MALE; PANAX; RATS; RATS, WISTAR; TISSUE ENGINEERING;

PANAX GINSENG;

EID: 21844432129     PISSN: 10763279     EISSN: None     Source Type: Journal    
DOI: 10.1089/ten.2005.11.835     Document Type: Article

References (40)

1. Chang, Y., Tsai, C.C., Liang, H.C., et al. In vivo evaluation of cellular and acellular bovine pericardia fixed with a naturally occurring crosslinking agent (genipin). Biomaterials 23, 2447, 2002.
2. Griffith, L.G., and Naughton, G. Tissue engineering: Current challenges and expanding opportunities. Science 295, 1009, 2002.
3. Shea, L.D., Smiley, E., Bonadio, J., et al. DNA delivery from polymer matrices for tissue engineering. Nat. Biotechnol. 17, 551, 1999.
4. Lee, K.Y., Halberstadt, C.R., Holder, W.D., et al. Breast reconstruction. In: Lanza, R.P., Langer, R., and Vacanti, J., editors. Principles of Tissue Engineering, 2nd Ed. San Diego, CA: Academic Press, 2000, pp. 409-423.
5. Zisch, A.H., Lutolf, M.P., Ehrbar, M., et al. Cell-demanded release of VEGF from synthetic, biointeractive cell ingrowth matrices for vascularized tissue growth. FASEB J. 17, 2260, 2003.
6. Saltzman, W.M. Delivering tissue regeneration. Nat. Biotechnol. 17, 534, 1999.
7. Tabata, Y. Tissue regeneration based on growth factor release. Tissue Eng. 9, 5, 2003.
8. Lee, YJ., Chung, E., Lee, K.Y., et al. Ginsenoside-Rgi, one of the major active molecules from Panax ginseng, is a functional ligand of glucocorticoid receptor. Mol. Cell. Endocrinol. 133, 135, 1997.
9. Chan, R.Y.K., Chen, W.F., Dong, A., et al. Estrogen-like activity of ginsenoside-Rgi derived from Panax notoginseng. J. Clin. Endocrinol. Metab. 87, 3691, 2002.
10. Attele, A.S., Wu, J.A., and Yuan, C.S. Ginseng pharmacology multiple constituents and multiple actions. Biochem. Pharmacol. 58, 1685, 1999.
11. Morales, D.E., McGowan, K.A., Grant, D.S., et al. Estrogen promotes angiogenic activity in human umbilical vein endothelial cells in vitro and in a murine model. Circulation 91, 755, 1995.
12. Losordo, D.W., and Isner, J.M. Estrogen and angiogenesis. Arterioscler. Thromb. Vasc. Biol. 21, 6, 2001.
13. Wang, H.S., Hwang, L.L., Sue, H.F., et al. A simple quantitative method for evaluation of angiogenesis activity. Assay Drug Dev. Technol. 2, 31, 2004.
14. Hagan, S., Hiscott, P., Sheridan, C.M., et al. Effects of the matricellular protein SPARC on human retinal pigment epithelial cell behavior. Mol. Vis. 9, 87, 2003.
15. Davidoff, A.M., Leary, M.A., Ng, C.Y.C., et al. Gene therapy-mediated expression by tumor cells of the angiogenesis inhibitor Flk-1 results in inhibition of neuroblastoma growth in vivo. J. Pediatr. Surg. 36, 30, 2001.
16. Malinda, K.M., Ponce, L., Kleinman, H.K., et al. Gp38k, a protein synthesized by vascular smooth muscle cells, stimulates directional migration of human umbilical vein endothelial cells. Exp. Cell Res. 250, 168, 1999.
17. Lee, O.K., Kim, Y.M., Lee, Y.M., et al. Sphingosine 1-phosphate induces angiogenesis: Its angiogenic action and signaling mechanism in human umbilical vein endothelial cells. Biochem. Biophys. Res. Commun. 264, 743, 1999.
18. Courtman, D.W., Pereira, C.A., Kashef, V., et al. Development of a pericardial acellular matrix biomaterial: Biochemical and mechanical effects of cell extraction. J. Biomed. Mater. Res. 28, 655, 1994.
19. Chang, Y., Lee, M.H., Liang, H.C., et al. Acellular bovine pericardia with distinct porous structures fixed with genipin as an extracellular matrix. Tissue Eng. 10, 881, 2004.
20. Sung, H.W., Huang, R.N., Huang, L.L.H., et al. Feasibility study of a natural crosslinking reagent for biological tissue fixation. J. Biomed. Mater. Res. 42, 560, 1998.
21. Courtman, D.W., Errett, B.F., and Wilson, G.J. The role of crosslinking in modification of the immune response elicited against xenogenic vascular acellular matrices. J. Biomed. Mater. Res. 55, 576, 2001.
22. Bryant, S.J., and Anseth, K.S. Controlling the spatial distribution of ECM components in degradable PEG hydrogels for tissue engineering cartilage. J. Biomed. Mater. Res. 64A, 70, 2003.
23. Bader, A., Schilling, T., and Teebken, O.E. Tissue engineering of heart valves: Human endothelial cell seeding of detergent acellularized porcine valves. Eur. J. Cardiothorac. Surg. 14, 279, 1998.
24. Tabata, Y., Miyao, M., Yamamoto, M., et al. Vascularization into a porous sponge by sustained release of basic fibroblast growth factor. J. Biomater. Sci. Polym. Ed, 10, 957, 1999.
25. Grant, D.S., Lelkes, P.I., Fukuda, K., et al. Intracellular mechanisms involved in basement membrane induced blood vessel differentiation in vitro. In Vitro Cell Dev. Biol. 27A, 327, 1991.
26. Venkov, C.D., Rankin, A.B., and Vaughan, D.E. Identification of authentic estrogen receptor in cultured endothelial cells. Circulation 94, 727, 1996.
27. Kim-Schulze, S., McGowan, K.A., Hubchak, S.C., et al. Expression of an estrogen receptor by human coronary artery and umbilical vein endothelial cells. Circulation 94, 1402, 1996.
28. Kim, H., Jr., Chen, X., and Gillis, N. Ginsenosides protect pulmonary vascular endothelium against free radical-induced injury. Biochem. Biophys. Res. Commun. 189, 670, 1992.
29. Babaei, S. and Stewart, D.J. Overexpression of endothelial NO synthase induces angiogenesis in a co-culture model. Cardiovasc. Res. 55, 190, 2002.
30. Vacanti, J.P., and Langer, R. Tissue engineering: The design and fabrication of living replacement devices for surgical reconstruction and transplantation. Lancet 354, 32, 1999.
31. Hodde, J.P., Record, R.D., Tullius, R.S., et al. Retention of endothelial cell adherence to porcine-derived extracellular matrix after disinfection and sterilization. Tissue Eng. 8, 225, 2002.
32. Ratner, B.D. Reducing capsular thickness and enhancing angiogenesis around implant drug release systems. J. Control. Release 78, 211, 2002.
33. Akao, T., Kobashi, K., and Aburada, M. Enzymatic studies on the animal and intestinal bacterial metabolism of geniposide. Biol. Pharm. Bull. 17, 1573, 1994.
34. Sung, H.W., Liang, I.L., Chen, C.N., et al. Stability of a biological tissue fixed with a naturally occurring crosslinking agent (genipin). J. Biomed. Mater. Res. 55, 538, 2001.
35. Sung, H.W., Huang, R.N., Huang, L.L.H., et al. In vitro evaluation of cytotoxicity of a naturally occurring crosslinking reagent for biological tissue fixation. J. Biomater. Sci. Polym. Ed. 10, 63, 1999.
36. Tsai, C.C., Huang, R.N., Sung, H.W., et al. In vitro evaluation of the genotoxicity of a naturally occurring crosslinking agent (genipin) for biological tissue fixation. J. Biomed. Mater. Res. 52, 58, 2000.
37. Murphy, W.L., Simmons, C.A., Kaigler, D., et al. Bone regeneration via a mineral substrate and induced angiogenesis. J. Dent. Res. 83, 204, 2004.
38. Perets, A., Baruch, Y., Weisbuch, F., et al. Enhancing the vascularization of three-dimensional porous alginate scaffolds by incorporating controlled release basic fibroblast growth factor microspheres. J. Biomed. Mater. Res. 65A, 489, 2003.
39. Westal, F.C., Rubin, R., and Gospodarowicz, D. Brain derived fibroblast growth factor: A study of its inactivation. Life Sci. 33, 2425, 1983.
40. Miyamoto, E., Odashima, S., Kitagawa, I., et al. Stability kinetics of ginsenosides in aqueous solution. J. Pharm. Sci. 73, 409, 1984.